PolymarketVerfügbarkeit prüfenKein KYC2% GebührVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle implizite Wahrscheinlichkeit
Ja 87.1%+1.0pt
Marktqualitat
74 / 100
Mittlere Qualität24h-Volumen
15.408,9 €
Liquidität
4447,9 €
Mittlere LiquiditätGeld / Brief
87.0% / 88.0%
Spread
1.0 pt
Enger SpreadComments
0
Marktdaten
Aktualisiert vor 7 Minuten
19. Aug. 26, 18:4730. Juni 27, 23:59
Trends
Regeln
This market will resolve to "Yes" if it is officially announced that a Biologics License Application (BLA) for intismeran autogene has been submitted to the U.S. Food and Drug Administration (FDA), or that the FDA has accepted such an application for review, by June 30, 2027, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- Intismeran autogene refers to the individualized neoantigen therapy developed by Moderna and Merck and evaluated in the Phase 3 INTerpath-001 trial (NCT05933577), also known as mRNA-4157 and V940, together with any brand, trade, or nonproprietary name later assigned to that product, as well as any renamed or modified version that the relevant company or the FDA identify as the same product or a direct continuation of the V940/mRNA-4157 program.
- A qualifying application must seek FDA licensure of intismeran autogene through a Biologics License Application (BLA).
- An original BLA or a resubmission of such a BLA following FDA action will qualify.
- The application may cover any indication.
Offene Märkte
Health & Medicine
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+0.1pt4%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 15.014,2 €
POLYMARKETHantavirus pandemic in 2026?
- No+0.1pt97%
- Yes-0.1pt3%
- Gesamtvolumen
- 15,3 Mio. €
- 24h-Volumen
- 8886,9 €
KALSHIMeasles cases in 2026?
- Above 3000-1.0pt96%
- Above 4000-1.0pt81%
- Above 6000+5.0pt29%
+2 weitere Ergebnisse
- Gesamtvolumen
- 782.253,8 €
POLYMARKETHeidi Overton confirmed as FDA Commissioner by which date?
- December 3172%
- October 3133%
- November 3033%
+1 weitere Ergebnisse
- Gesamtvolumen
- 6513,9 €
KALSHIWhen will Heidi Overton be confirmed as Commissioner of the FDA?
- Before Aug 1, 202774%
- Before Apr 1, 202767%
- Before Jan 1, 202767%
+2 weitere Ergebnisse
- Gesamtvolumen
- 4487,1 €
- 24h-Volumen
- 3674,5 €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+2.0pt68%
- June 30,-7.5pt24%
- Gesamtvolumen
- 38.569,6 €
- 24h-Volumen
- 3414,9 €
- Will 3 mg THC beverages qualify as hemp under federal law?
- New pandemic in 2026?
- Measles cases in U.S. by August 31?
- How many human screwworm cases will be reported in the United States in 2026?
- Which countries will report an Ebola disease case before October?
- Hantavirus vaccine in 2026?
- Ebola pandemic in 2026?
- FDA decision: Brepocitinib by Priovant Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Skin cancer vaccine BLA submitted by June 30, 2027??
- Polymarket bewertet Yes mit 87% (Stand: 21. August 2026).
- Wann wird Skin cancer vaccine BLA submitted by June 30, 2027? entschieden?
- Skin cancer vaccine BLA submitted by June 30, 2027? soll am 30. Juni 2027 entschieden werden.
- Wie wird Skin cancer vaccine BLA submitted by June 30, 2027? abgerechnet?
- Polymarket rechnet diesen Markt wie folgt ab: This market will resolve to "Yes" if it is officially announced that a Biologics License Application (BLA) for intismeran autogene has been submitted to the U.S. Food and Drug Administration (FDA), or that the FDA has accepted such an application for review, by June 30, 2027, 11:59 PM ET.